Polyclonal antibodies have been raised against four 16 residue peptides with sequences taken from the C-terminal quarter of the human cytoplasmic dynein heavy chain. The sites are downstream from a known microtubule-binding domain associated with the``stalk'' that protrudes from the motor domain. The antisera were assayed using bacterially expressed proteins with amino acid sequences taken from the human cytoplasmic dynein heavy chain. Every antiserum reacted speci®cally with the appropriate expressed protein and with pig brain cytoplasmic dynein, whether the protein molecules were denatured on Western blots or were in a folded state. But, whereas three of the four antisera recognized freshly puri®ed cytoplasmic dynein, the fourth reacted only with dynein that had been allowed to denature a little. After af®nity puri®-cation against the expressed domains, whole IgG molecules and Fab fragments were assayed for their effect on dynein activity in in vitro microtubule-sliding assays. Of the three anti-peptides that reacted with fresh dynein, one inhibited motility but the others did not. The way these peptides are exposed on the surface is compatible with a model whereby the dynein motor domain is constructed from a ring of AAA protein modules, with the C-terminal module positioned on the surface that interacts with microtubules. We have tentatively identi®ed an additional AAA module in the dynein heavy chain sequence, which would be consistent with a heptameric ring.
Introduction
Cytoplasmic dynein (CD) is a multisubunit protein that uses ATP to translocate along microtubules (Holzbaur & Vallee, 1994) . It has roles in cytoplasmic vesicle motility and, during mitosis, in chromosome separation and spindle organization (Schroer, 1994; Vallee & Sheetz, 1996) . Dynein puri®ed from brain tissues is a homodimer of $500 kDa heavy chains (CDHCs) together with two intermediate chains (CDICs) of 70-80 kDa, four light intermediate chains (CDLICs) of 50-60 kDa and various light chains (CDLCs) (Holzbaur & Vallee, 1994) . This complex drives microtubule sliding in vitro (Vallee & Sheetz, 1996) . The dynactin protein complex that co-puri®es with CD (Gill et al., 1991; seems to be needed for most of its in vivo activities (Karki & Holzbaur, 1999) but, in vitro, recombinant CDHC can by itself produce microtubule gliding with a velocity similar to that of native dynein (Mazumdar et al., 1996) .
The N-terminal 1200-1300 residues dimerise as a stem domain that interacts with CDIC and tethers dynein to its cargo (Habura et al., 1999; Lyadurai et al., 1999) . The remaining $380 kDa form the globular catalytic head domain, responsible for direct interaction with microtubules, as well as for ATP hydrolysis and force production (Vallee, 1993) . The central region contains four phosphatebinding loop (P-loop) motifs (Gee & Vallee, 1998; Vallee, 1993) , each part of a bona ®de nucleotidebinding site (Mocz et al., 1998) . However, ATPase activity is lost if the ®rst P-loop is truncated or if the polypeptide is cleaved there by UV light in the presence of vanadate (Lee-Eiford et al., 1986) . The head domain has been expressed without the stem in two systems (Gee et al., 1997; Koonce & Samso, 1996 ; Koonce, 1997) and shown to bind microtubules in an ATP-sensitive fashion and to undergo UV-vanadate cleavage. Any further truncation affects ATP binding or ATPase activity, though some microtubule binding persists if all four Ploops are removed or if $1170 residues are cut from the C terminus. A $300 residue region after the last P-loop includes two alpha-helical segments separated by a small globular domain. Gee & Vallee (1998) found that an expressed domain consisting only of this region was able to bind well to microtubules; in electron microscope images, shadowed specimens resembled the stalk that has been seen to extend from intact heads of both cytoplasmic and axonemal dyneins and to bind to axonemal microtubules in situ (Goodenough & Heuser, 1989; Burgess, 1995) . Experiments by Koonce (1997) support the existence of binding activity in this region but indicate that regions downstream of the stalk sequence may also have some af®nity for microtubules.
A recent search of the sequence database (Neuwald et al., 1999 ) using a reference set of sequences in the AAA ATPase family (Langer, 2000; Patel & Latterich, 1998) revealed the presence of six copies of the AAA module within the dynein motor domain sequence (see Figure 1) , leading to the current model (Vale, 2000; King, 2000) of the dynein motor domain as a ring of connected subunits. Each of the four P-loops is associated with an AAA module but the analysis (Neuwald et al., 1999) identi®ed two additional modules in which P-loops are no longer recognizable as such. Here, we present evidence for a seventh module, also lacking a P-loop, which correlates with electron microscopic images that show each individual dynein head as a ring of at least seven globular lobes arranged around a central cavity (Samso et al., 1998) . The modules without P-loops are highly conserved in sequence, despite having no known function. We have made antibodies to sequences that are found within the ®nal two modules and are predicted to lie on an exposed surface. An investigation of their properties adds new details to the model of the motor domain and suggests that at least one of the AAA modules lacking a P-loop may be involved in interacting with microtubules.
Results

Expressed proteins and synthetic peptides
Since previous work suggested that it can be dif®cult to elicit good antibodies to the dynein heavy chain (Criswell et al., 1996; Go È nczy et al., 1999; Kandl et al., 1995; Li et al., 1994; Vaisberg et al., 1993 Vaisberg et al., , 1996 , we used peptides as antigens and expressed proteins for af®nity puri®cation. The criterion for choosing the peptides was that they should be soluble and hydrophilic, both for ease of handling and because amino acid sequences with such properties are likely to lie on the surface of a large molecule. Because the full sequence of human CDHC is unknown, we refer to residues numbered from the start of the full rat sequence. Clone KIAA0325, the C-terminal half of human CDHC has only 32 differences (26 of which are conservative changes) from rat residues 2558-4644, with no gaps or insertions. Most of the substitutions, including four of the six dissimilar changes, are in the last 400 residues, beyond the proposed AAA domains (Figure 1 ) or in between the last two AAA domains. The expressed fragment H1 of human CDHC is identical with the rat sequence, while H2 has eight conserved differences between the two species. Peptides Pt1 and Pt2 lie within H1, Pt3 and Pt4 within H2. Pt3 includes two residues that vary between rat and human, the other three are fully conserved.
Isolation of pig brain cytoplasmic dynein
Cytoplasmic dynein was prepared from pig brain by extracting a pellet of Taxol-stabilised microtubules with Mg-ATP (Amos, 1989) , followed by sucrose-gradient fractionation to separate dynein from other proteins that associate with microtubules in an ATP-dependent manner (Paschal et al., 1987 . Figure 2 shows fractions from a 5 %-20 % (w/v) sucrose density-gradient in Tris/KCl buffer. Two peaks gave high molecular mass bands on SDS-PAGE (Figure 2(a) ) but immuno-analysis with anti-dynein antibodies, against both CDHC and CDIC (Figure 2(b) ), showed that only the second peak contained dynein. As expected, dynactin comigrates with dynein under these conditions. High molecular mass proteins in the upper peak (fractions 2-5) were heat-resistant and did not react with any of the antibodies used Figure 1 . Plan of the cytoplasmic dynein heavy chain (CDHC). The predicted secondary structures (Rost & Sander, 1993) of the N-terminal and C-terminal halves of the rat CDHC sequence (Mikami et al., 1993; Zhang et al., 1993) are represented by vertical bars: alpha-helical regions as long bars, beta-sheet regions as shorter bars, random coil as gaps. Each half contains two Ploops (P1-P4). Removal of the N-terminal fragment (N to F) produces the minimal motor domain. Regions corresponding to expressed proteins H1 (3537-3802) and H2 (3870-4071) are indicated. Continuous horizontal lines above the secondary structure mark the six proposed AAA domains (Neuwald et al., 1999) . The broken line marks a possible seventh globular domain. The two long helical regions before H1 are thought to form an antiparallel coiled-coil (Gee et al., 1997) . Prediction carried out via http://pbil.ibcp.fr/NPSA. in this immuno-assay, including anti-MAP2 (Sigma). The result of N-terminal protein sequencing indicated that they might be MAP1a or MAP1b.
Characterization of antisera
Rabbit antisera, collected 14 days after the second boost, were tested by ELISA against H1 and H2 (Figure 3 (a) and (b) and against pig brain dynein (Figure 3(c) ). Anti-Pt4 showed extremely high af®nity to native dynein, anti-Pt2 and anti-Pt1 showed somewhat lower af®nities. Anti-Pt3 showed very low af®nity to fresh dynein but reacted as strongly as anti-Pt4 with dynein that had been left at 4 C for two weeks (Figure 3(c) ). The incubation period did not increase the reactivity of dynein with the other three antisera. The antisera to Pt1, Pt2 and Pt4 were subjected to antigen af®nity puri®cation on Sepharose 4B resin coupled to H1 or H2. Antibodies eluted with glycine are anti-Pt1G, anti-Pt2G and anti-Pt4G; those eluted with triethylamine are anti-Pt2T and antiPt4T. Figure 4 (c) demonstrates that anti-Pt4G, antiPt1G, anti-Pt2T and anti-Pt2G interacted speci®- 
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cally and strongly with native dynein molecules, whereas anti-Pt4T failed to react. The four good af®nity-puri®ed antibody fractions (0.1-0.2 mg/ml) could all be diluted to 1:4000. Western blotting further proved that these antibodies cross-reacted speci®cally with the $500 kDa CDHC band (Figure 4(b) ).
Effect of antibodies on motility in vitro
Video-enhanced differential interference contrast (VE-DIC) microscopy showed that the puri®ed dynein could move microtubules in the presence of Mg-ATP. Figure 5 illustrates microtubules sliding over a coverslip coated with approximately 0.2 mg/ml of freshly prepared CD. Microtubule gliding occurred in a continuous unidirectional fashion, and lasted for as long as ten hours in undisturbed preparations. A typical sliding velocity measurement was 0.46(AE0.22) mm/second. An estimate of the amount of dynein bound, made by comparing the intensities of stained bands on an SDS/polyacrylamide gel, of a drop of protein before and after the ®ve minute incubation period (Vallee & Sheetz, 1996) , indicated that $80 % stuck to the surface. After the dynein-coated coverslip was incubated with anti-Pt4G instead of PBS/motility buffer, microtubule sliding resembled the effect of using a much lower concentration of dynein. Very few microtubules were seen on the surface of the coverslip. In contrast, antibodies anti-Pt1G, anti-Pt2G,T and R-325 had no obvious effect on motility; microtubules were seen gliding as smoothly and continuously as in the control. The inhibitory effect of anti-Pt4G was not due to crosslinking of dynein molecules by IgG. Anti-Pt4G Fab was even more effective than anti-Pt4G IgG, probably because of being at a higher molar concentration. A total of 1 mg in 10ml of antibody was applied for each motility assay. Thus, up to 1 mg of IgG or Fab could react with $1.6 mg ($80 % of 2 mg) of dynein on the surface; a molar ratio of $6:1 (IgG to dynein) or $18:1 (Fab to dynein). After treatment with this concentration of antiPt4G Fab, most of the surface was empty of microtubules, though in small areas (e.g. see Figure 6 ) a few microtubules attached and moved brie¯y before detaching and returning to the medium. The short movements occurred at normal sliding velocity (measured as 0.48(AE0.22) mm/second).
Discussion Peptides and antibodies
We have produced four high-af®nity antibodies to different regions of the dynein heavy chain sequence (Figures 7 and 8 ), using peptides as antigens. Previous work (Criswell et al., 1996; Go È nczy et al., 1999; Kandl et al., 1995; Li et al., 1994; Vaisberg et al., 1993 Vaisberg et al., , 1996 has shown that it can be dif®cult to elicit antibodies to the dynein heavy chain but the strategy used here proved to be very successful. The original criterion for choosing the antigenic sites was that the peptides should be predicted to be soluble and hydrophilic (Hopp & Woods, 1981; Wilkinson & Harrison, 1991) , both for ease of handling and because amino acid reacts as well as our anti-Pt4G but has no effect on motility.
sequences with such properties are likely to lie on the surface of a large molecule. All four antisera were found to interact speci®cally with the appropriate expressed proteins in a folded state and three interacted in a speci®c manner with wholly intact cytoplasmic dynein molecules. After af®nity puri®cation against expressed proteins corresponding to segments of CDHC, anti-Pt4G and anti-Pt1G showed the highest af®nities for native dynein but even anti-Pt2T and anti-Pt1G could detect dynein after dilution to $0.1 mg/ml (Figure 4) . Anti-Pt3 interacted with folded H1 and with``old'' whole dynein, though not with freshly isolated native protein. This suggests that Pt3 lies on a part of the surface that is accessible to antibodies only when the molecule loses some aspect of its native conformation. Freshly isolated cytoplasmic dynein usually appears quite compact, with its two motor domains (heads) in close association (Amos, 1989) , as shown by the examples of similar images obtained recently (Figure 8(c) ). In samples that are no longer active in motility assays, the heads tend to separate and appear more disordered.
Only one previous report, using antibodies directed against the region containing the ®rst two P-loops of CDHC, has demonstrated inhibition of motility; however, it required the application in vitro of 8-12 mg/ml of this antibody (Vaisberg et al., 1993) . It is not clear how speci®c the interaction would be at such high concentrations. We therefore used a lower antibody concentration, 0.1 mg/ml, throughout our experiments. Most of the antibodies we tried in motility assays had no effect on the interaction between fresh dynein and microtubules; microtubule sliding continued as in untreated specimens. However, one antibody had a marked effect on binding and motility at this concentration. Very few microtubules were able to bind to a glass surface that had been coated with dynein and then treated with anti-Pt4G. Any microtubules that bound to and slid over the surface did so for only brief periods, as if interacting with dynein at very low surface density. The most likely explanation is that anti-Pt4G binds to a site on dynein where it directly blocks the dyneinmicrotubule interaction. It is unlikely, for example, that binding of antibody causes dynein to release from the glass surface, since control molecules were attached ®rmly enough to sustain microtubule sliding for an hour or more. The Pt4 antigenic site may form part of the tubulin-biding interface or must at least lie very close by. In contrast, antiPt1 and anti-Pt2 recognised fresh dynein on ELISA plates but had no detectable effect on motility. They presumably bind to sites on the molecule where they do not interfere with its interactions with microtubules.
Motor domain as a ring of AAA subunits
The minimal motor domain seen by EM (Samso et al., 1998) has the appearance of a ring of at least seven subunits. It has been proposed (Vale, 2000) that the AAA protein modules predicted by Neuwald et al. (1999) correspond to six subunits. The alignment of sequences within the proposed AAA modules is illustrated for mammalian CDHC in Figure 7 . Four modules include the obvious Ploops but a further two modules without P-loops lie on the other side of the stalk region (see Figure 8(a) ). Moreover, secondary structure predictions (Figure 1) are consistent with the existence of a seventh module (S0) upstream of the ®rst P-loop. Since there is also some sequence homology, at least in the region of the Walker A and Walker B motifs (Figure 7) , it is possible that the structural fold of S0 also resembles an AAA protein. The region at the C terminus that is not yet accounted for is also large enough to accommodate a separate subunit but the near-absence of predicted betasheet in this region suggests a distinctly different fold from that of S1-S6.
As can be seen in Figure 7 , three of the peptides we chose as antigens (Pt1, Pt2, and Pt4) lie within AAA modules S5 or S6. The antibodies to these peptides all interact with intact native dynein. In the structure of the Escherichia coli heat-shock protein HSLU, a complete ring complex of AAA proteins that has been solved to atomic resolution (Bochtler et al., 2000) , the regions corresponding to Pt1 and Pt4 lie on the outer surface of the complex. In the case of Pt2, the dynein sequence has an extra loop adjacent to a piece of sequence that is exposed on HSLU. These results are fully consistent with the postulate that the dynein motor domain is a ring of linked modules, each with a fold homologous to an AAA protein. Pt3 occurs in the linker sequence between subunits S5 and S6, and must lie somewhere where it is protected from antibodies when dynein is in its compact conformation. Possible sites include those between the two heads, on the inside of the ring of subunits or between subunits. The Pt3 region may be less important functionally than the other three peptides, since its sequence is more divergent among different species. Rat cytoplasmic dynein heavy chain sequence (residues 1874-4319). Segments labelled Box II-VIII, Walker A, B or Motif C (residues in red or blue) were identi®ed by their homology to other members of the AAA-ATPase family (Neuwald et al., 1999) . The sequence was originally shown to contain six such domains in succession (S1-S6). Residues in red are identical with those in many other members of the family. Variable loops between the conserved segments of the AAA family are shown in black; the ®nal set of sequences in black presumably connects neighbouring``subunits''. Sequences in the ®rst part of a possible subunit preceding S1 (referred to here as S0) are shown for three distant species (rat, Dictyostelium and Saccharomyces cerevisiae). Peptides used here as antigens against mammalian CDHC are shown in green; Pt1 is in Box VII' of S5, Pt2 is just before Box VII'' of S5, Pt3 comes after S5, Pt4 covers most of the Walker-A region of S6. The sequences of expressed proteins H1 and H2 are shown underlined.
Dynein-microtubule interface
In experiments with expressed proteins, microtubule-binding activity was found in the C-terminal half of the sequence, after the four P-loops (Gee et al., 1997; Koonce, 1997; Koonce & Tikhonenko, 2000) . Gee et al. narrowed down the binding activity to just the loop between the two long helical regions. However, some parts of the main surface of the globular head may also make contact with tubulin during the ATPase cycle. Only the globular tip of the coiled-coil stalk has been clearly observed to interact with microtubules by electron microscopy (Goodenough & Heuser, 1989; Burgess, 1995) but the images obtained probably represent particularly stable stages in the enzymatic cycle. It seems unlikely that a dynein head can move distances as large as 12 nm (Burgess, 1995) simply by tilting around the tip of the stalk. A possible role for subunits that lack ATPase activity is to make transient contact with tubulin. Koonce (1997) found that a construct corresponding to residues 3678-3818 of Dictyostelium dynein (residues 3596-3736 of rat CDHC), downstream of the stalk domain, bound weakly to microtubules. This result suggests that part of subunit S5 may interact directly with tubulin. Since the end of this latter region overlaps with Pt1, it is slightly surprising that anti-Pt1 did not interfere with microtubule sliding, especially since Pt1 shows high similarity even between cytoplasmic and axonemal dyneins. An alternative explanation for the effect of anti-Pt4 is that it has an indirect effect and, by binding to S6, affects the conformation of the motor domain elsewhere; in this case, S6 would not need to be at or close to the tubulin-binding interface.
However, results implicate the involvement of subunit S6 in the interaction. Not only do antibodies to Pt4 prevent microtubules from attaching to dynein coated glass but we have also found that our expressed protein H2 can be pelleted with microtubules (our unpublished results). Pt4 is less conserved in sequence than Pt1 but the charged and hydrophobic residues are mostly conserved. Thus, in a preliminary scheme for the layout of CDHC (Figure 8(b) ), we have tentatively put S6 near the top of the head, close to the free end of the stalk, where this part of the surface would be in a position to interact with the next microtubule. We hope to substantiate this by immuno-electron microscopy to identify the site of Pt4 on the dynein molecule. Figure 8 . Structure of cytoplasmic dynein heavy chain. (a) Plan of the major domains of CDHC. The numbers refer to the rat amino acid sequence. Fragment A can be removed without affecting ATPase activity or ATP-dependent microtubule binding (Gee & Vallee, 1998) . Subunits S1-S6 were identi®ed by sequence homology as AAA modules (Neuwald et al., 1999) . S0 is a proposed seventh subunit (see Figure 7) . The antiparallel coiled-coil (CC) domain lies between S4 and S5. Numbers i to iv in S5-S6 indicate the positions of the four peptides (Pt1-Pt4) used to raise antibodies in the present work. Antibody v (R-325, Santa Cruz) was raised against C-terminal residues 4320-4644. (b) Tentative diagrammatic model of a cytoplasmic dynein molecule, which consists of two heavy chains dimerised via the Nterminal parts of the heavy chains and their associated intermediate (CDICs) and light intermediate chains (CDLICs) . The coiled-coil stalks also appear to dimerise under some conditions. The exact relationship between the two heads is not known, nor the relative arrangement of the globular AAA domains in each head but a tentative placing of subunits 4-6 is shown. The order of the remaining subunits is unknown. Since there is an extensive stretch of amino acid sequence between the stem domain and S0, the ®rst subunit of the heptamer, the latter may be positioned far from the top of the stem. (c) Electron microscope images of two individual dynein molecules freshly isolated from pig brain, contrasted in negative stain. The scale bar represents 50 nm.
Materials and Methods
Protein cloning, expression and purification
The KIAA0235 plasmid (Kazusa DNA Research Institute, Japan) subcloned into pBlueScriptII KS, served as the template for cloning and expression of two fragments, H1 and H2 (Figure 1 ) into vector pQE system (Qiagen). The fragments were chosen to have a high hydrophilicity index (Hopp & Woods, 1981) and a low insolubility factor (Wilkinson & Harrison, 1991) , using the program DNAid (freeware, F. Dardel, E-mail: fred@-botrytis.polytechnique.fr).
Details of cell culture and harvesting will be described elsewhere. Inclusion body pellets containing H1 were prepared by standard protocols (Sambrook et al., 1989) and resuspended in Ni-column binding buffer (100 mM sodium phosphate (pH 8.0), 300 mM NaCl, 10 mM TrisHCl, 1 mM PMSF (phenylmethyl-sulfonyl¯uoride), 10 mM imidazole, 2.5 mM b-mercaptoethanol). H1 was denatured in 8 M urea and loaded onto a Ni-NTA column. Proteins bound to the column were refolded there at room temperature with a gradient of decreasing urea and increasing b-mercaptoethanol and then eluted with a gradient of 20 mM to 500 mM imidazole in native elution buffer (50 mM sodium phosphate (pH 7.2), 300 mM NaCl, 0.1 mM PMSF, 5 mM b-mercaptoethanol and 10 % glycerol) at 4 C. H2, loaded under native conditions at 4 C on a 10 ml Ni-NTA Super¯ow column, was eluted with a linear gradient of 20 mM to 500 mM imidazole in native elution buffer.
Production of antipeptide antisera
Peptides to be used as antigens were synthesized with an additional C-terminal cysteine residue by Peptide Products Ltd. (Oldham, UK). Their sequences were predicted to be soluble and hydrophilic: Pt1, VLKAERPDVDEKRSDLC; Pt2, LENLKREAAEVTRK-VEC; Pt3, FLRGNEIVLSAGSTPRC; Pt4, VPGYDASGH-VEDLAAEC.
Each peptide was coupled to the carrier protein, keyhole limpet hemocyanin (KLH), through the C-terminal cysteine residue, using 3-maleimidibenzoyl-N-hydroxysuccinimide (MBS) as coupling reagent (Kitagawa, 1976; Liu et al., 1979) according to the manufacturer's protocol (Pierce, USA). Rabbits were immunized by Animal Services of Murex Biotech (University of Cambridge, UK) according to the standard schedule (Harlow & Lane, 1988) . Test bleeds were assayed against H1 or H2 proteins either by enzyme-linked immunosorbent assay (ELISA) or dot blots.
Purification of antibodies and Fab fragments
Rabbit polyclonal antibodies were af®nity-puri®ed (Harlow & Lane, 1988) using H1 or H2 linked to CNBractivated Sepharose-4B (Amersham Pharmacia Biotech). The gels in PBS (10 mM sodium phosphate (pH 7.2), 150 mM NaCl, 2.7 mM KCl) were packed into 5 ml BioRad Dispo-columns. Filtered antiserum, 20 ml mixed with 80 ml of PBS, was loaded and antibodies were eluted in 10 ml of 0.15 M glycine (pH 2.5) and then 10 ml of 100 mM triethylamine (pH 11.5). Each 600 ml fraction was neutralized with 100 ml of 1 M Tris-HCl (pH 7.4). Second antibodies used in ELISA or blot assays were alkaline phosphatase (AP) or horseradish peroxidase (HRP) conjugated goat anti-rabbit IgG (Sigma) diluted 1:2000. IgG was digested into Fab fragments using the ImmunoPure Fab Preparation Kit (Pierce). The secondary antibody was HRP-conjugated anti-Fab (Jackson Immuno Research Lab Inc), diluted 1:2000. Antibody IgG and Fab concentrations were determined with values of E1 % (279 nm) 14.0 and 14.8, respectively (Nisonoff et al., 1970) .
Control antibodies
CDHC was detected using goat polyclonals C-18 and S-19 (Santa Cruz Biotechnology), to the C and N termini (working dilution 1:100). Anti-goat IgG (Sigma) was diluted 1:4000. Rabbit polyclonal IgG,R-325, against residues 4320-4644 of CDHC (working dilution 1:200), was also from Santa Cruz. Mouse monoclonal anti-P150 and anti-P50 (AbCam), against dynactin polypeptides P150 and P50 (working dilutions 1:500); IC74.1 (Covance) to CDIC (working dilution 1:2000); and anti-MAP2 (Sigma) (working dilution 1:500) were all detected with AP or HRP-conjugated anti-mouse IgG (Sigma) against mouse Fc (working dilution 1:2000).
Microtubule and dynein preparation
Tubulin was puri®ed from pig brain and microtubules were polymerized in BRB80 (80 mM Pipes (pH 6.8), 1 mM EGTA, 2 mM MgSO 4 , 1 mM DTT, 0.1 mM PMSF) containing 20 mM Taxol (Hyman et al., 1991) . Pig brain dynein was prepared using a combination of published methods (Amos, 1989; Paschal et al., 1987) . N-terminal protein sequencing was carried out by Sew Peak-Chew (IRC, MRC centre).
In vitro motility assay
Motility was observed by video-enhanced differential interference contrast microscopy in a $10 ml perfusion chamber (Allan, 1993) made from a microscope slide (Chance Propper Ltd., UK) and glass coverslip (No.1, 18 mm Â 18 mm, Menzel-Glasser, Fisher, Germany). Dynein (10 ml of 0.1-0.2 mg/ml) was dropped onto the coverslip (drop diameter $5 mm) and incubated for ®ve minutes (Paschal et al., 1987) . The glass surfaces were blocked with 10ml of 0.025 % (w/v) BSA (Sigma) in motility buffer (50 mM Tris-HCl (pH 7.4), 50 mM KCl, 0.5 mM EDTA, 5 mM MgSO 4 ) plus 0.1 mM Mg-ATP (Sigma), 20 mM Taxol and Protease Inhibitor Cocktail (5ml per 1 ml) (Sigma) at room temperature for one minute. The chamber was then loaded with 10 ml of a 1:1 mixture of PBS and motility buffer (control), or the same buffer mix containing 1 mg of anti-DHC antibodies, and incubated at 30 C for three minutes. Free protein was removed by a quick wash with 10 ml of motility buffer and ®nally 10 ml of 0.1 mg/ml Taxol-stabilised microtubules in motility buffer plus 1-2 mM Mg-ATP were loaded. Captured video frames at one second intervals were analysed using RETRAC (Dr N. Carter, E-mail: ncarter@mcri.ac.uk).
Further processing of digital images was carried out using Photoshop and Illustrator (Adobe). Graphs were plotted using Cricketgraph and Illustrator.
Electron microscopy
The cytoplasmic dynein fraction was diluted into HB buffer (50 mM Pipes-K and 30 mM Hepes-K (pH 7.0), 1 mM EGTA, 2 mM MgSO 4 , 1 mM DTT, 0.1 mM Mg-ATP and 0.1 mM PMSF) before negative staining with tannic acid/phosphotungstic acid as described by Kensler et al. (1985) or Lanzavecchia & Bellon (1994) .
Note added in proof
Mocz & Gibbons have recently modelled a detailed atomic structure for a ring of six AAA modules in a dynein motor domain (Mocz, G. & Gibbons, I. R. (2001) . Structure, 9, 93-103).
